Document is current
Any future updates will be listed below
-
Authors
An, Andy Y.
Baghela, Arjun
Zhang, Peter
Blimkie, Travis M.
Gauthier, Jeff
Kaufmann, Daniel E.
Acton, Erica
Lee, Amy H. Y.
Levesque, Roger C.
Hancock, Robert E. W.
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (FDN-154287)
Gouvernement du Canada | Canadian Institutes of Health Research (COVID-19 Rapid Research Funding)
Gouvernement du Canada | Canadian Institutes of Health Research (CGS-D)
Gouvernement du Canada | Canadian Institutes of Health Research (COVID-19 Rapid Research Funding)
- License Information
-
More Information
Article History
Received: 21 February 2025
Accepted: 9 December 2025
First Online: 19 December 2025
Competing Interests
: RH has filed for patent protection all-cause sepsis endotype signatures, utilized here for analysis, and licenced these to Sepset Biosciences Inc., a subsidiary of Asep Medical Holdings Inc., in which he has a significant ownership position and serves as CEO and Board Chair. PZ is employed by Sepset Biosciences. The other authors declare no competing interests.
